SCOPUS 정보 검색 플랫폼

Volumn 20, Issue 3-4, 2002, Pages 14-19

Characteristics, supply and use of the hydrofluorocarbons HFA 227 and HFA 134a for medical aerosols in the past, present and future. Manufacturers perspectives

(1) Pischtiak, Anja H a

a Solvay Pharmaceuticals GmbH (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1,1,1,2,3,3,3 HEPTAFLUOROPROPANE; BECLOMETASONE DIPROPIONATE; BETA1A INTERFERON; CROMOGLYCATE DISODIUM; CROMOGLYCATE DISODIUM PLUS REPROTEROL; FLUORINATED HYDROCARBON; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; INSULIN; MORPHINE; NEDOCROMIL SODIUM; NORFLURANE; PARATHYROID HORMONE; SALBUTAMOL; SALBUTAMOL SULFATE; SALMETEROL; SERETIDE EVOHALER; SEVERENT; SOLKANE; VENTOLIN EVOHALER;

AEROSOL; CHEMICAL INDUSTRY; CLINICAL TRIAL; DIABETES MELLITUS; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG QUALITY; DRUG SOLUBILITY; HUMAN; INSULIN TREATMENT; METERED DOSE INHALER; MULTIPLE SCLEROSIS; OSTEOPOROSIS; PAIN; PHYSICAL CHEMISTRY; REVIEW; SHELF LIFE;

EID: 0036510404 PISSN: 0392839X EISSN: None Source Type: Journal
DOI: None Document Type: Review

Times cited : (2)

References (27)

1
- 0010166866
- London 7th May
- (1997) CPMP/391/97 Consolidation of CPMP Reviews of Alternatives to Chlorofluorocarbon Propellants

2
- 0010116008
- Brussels, 13 July
- (1994) CPMP Result of the Co-ordinated Review of 1,1,1,2-Tetrafluoroethane HFA-134a Meeting of 12-13 July 1994

3
- 0010116413
- Brussels, 19 October
- (1994) CPMP Results of the Co-ordinated Review of Glaxo Inhalation Grade 1,1,1,2-Tetrafluoroethane HFA-134a, Meeting of 10-19 October 1994

4
- 0010066183
- London, 13 September
- (1995) CPMP/503/95 CPMP Result of the Co-ordinated Review of 1,1,1,2,3,3,3-Heptafluoropropane (HFA-227)

5
- 0010176790
- Bundesinstitut für Arzneimittel und Medizinprodukte, Bekanntmachung über die Zulassung und Registrierung sowie die Verlängerung der Zulassung von Arzneimitteln - Ausnahmen vom Verbot bestimmter die Ozonschicht abbauender Halogenkohlenwasserstoffe nach der FCKW-Halon-Verbots-Verordnung - vom 20. Dezember 1999: Prof. Dr. A.G. Hildebrandt, Bonn, den 20. Dezember 1999, Bundesanzeiger L-A 351-87384/99 vom 7. Januar 2000

6
- 0010172739
- April 2000 and 2001 TEAP Reports, Montreal Protocol on Substances that Deplete the Ozone Layer

7
- 0010065374
- Hans-Böckler Allee 20, D 30173 Hannover
- Leaflet "MDIs and the Environment"

8
- 0010066986
- Final Report 12/09/00
- Enviros March Study on the Use of HFCs for Metered Dose Inhalers in the European Union

9
- 0010127687
- IPAC Presentation on HFC MDIs to the European Commision Climate Change Policy Group, 19 September 2000, Brussels

10
- 0010065966
- FDA CDER October 1998 Draft Guidance for Industry - Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Products - Chemistry, Manufacturing, and Controls Documentation, November 05
- (1998)

11
- 84889624247
- Qualification of HFA 227ea versus HFA 134a for use as a propellant in MDIs
- May 14-18, 2000 Palm Harbor at Tarpon Springs, Florida
- Proceedings of RDD VII , pp. 519-522
- Pischtiak, A.H.¹

12
- 0010066987
- Institut für Luft- und Klimatechnik: ILK Report-Nr. 22/1377/91 of 03.01.1991
- Messung des Dipolmoments von H-FKW 227
- Neubert, J.¹

13
- 0003591850
- REFPROP 6.0 "Thermodynamic and Transport Properties of Refrigerants and Refrigerant Mixtures"
- Copyright
- (1998) NIST Standard Reference Database 23, Version 6.01

14
- 0010065375
- (1991) Journal of Molecular Spectroscopy , vol.146 , pp. 402-408
- Heineking, H.¹ Stahl, W.² Thomsen, C.³

15
- 70350328149
- Verlag der Wissenschaften, Berlin
- Moderne Meßmethoden der Physik Teil b
- Eder, F.X.¹

16
- 0010127688
- Solubility of Oxygen in Solkane 227 pharma and Solkane 134a pharma at different temperatures
- Dec 11-12, London, UK
- (2000) Proceedings of Drug Delivery to the Lungs XI
- Pittroff, M.¹ Schwarze, T.²

17
- 84887129841
- Solubility of Silicone Oil in Solkane 227 pharma and Solkane 134a pharma
- Dec 11-12, London, UK
- (2000) Proceedings of Drug Delivery to the Lungs XI
- Pittroff, M.¹ Pischtiak, A.² Schwarze, T.³

18
- 0010126342
- Predictive drug delivery to the Respiratory System - The COPHIT Approach
- Jan 28/29, London, Management Forum
- (2002) Proceedings Portable Inhalers Conference
- Clayborough, R.¹

19
- 0037485143
- Density, excess molar volume, and vapor pressure of propellant mixtures in metered-dose inhalers: Deviation from ideal mixtures
- (1998) Proceedings RDD VI , pp. 339-443
- Tzou, T.-Z.¹

20
- 84964382394
- Moisture transport into the MDI
- (1998) Proceedings RDD VI , pp. 471-474
- Williams, G.¹ Tcherevatchenkoff, A.²

21
- 0010128313
- (1998) "Hygroscopiscity of drugs for inhalation", RDD VI
- Yu, P.Y.¹ Chan, H.-K.²

22
- 0010066806
- "The use of an image analysis system to evaluate homogenisation efficacy during the manufacture of a hydrofluoroalkane metered dose inhaler concentrate"
- The Aerosol Society
- (1998) Proceedings of Drug Delivery to the Lungs IX
- Nield, L.J.¹ Hannay, M.C.F.² Berner, B.³ Oliver, M.J.⁴

23
- 0010128314
- MDI technology: Can it meet the challenges of CFC replacement and increasing regulatory demand?
- (1998) Proceedings of RDD VI , pp. 123-131
- Howlett, D.J.¹

24
- 0031847906
- (1998) Drug Development and Industrial Pharmacy , vol.24 , Issue.8 , pp. 763-770
- Williams, R.O.¹

25
- 0010065580
- The modulation of clouds generated by pMDIs
- Vienna June 12-16
- (1999) 12th International Congress ISAM
- Ganderton, D.¹ Lewis, D.² Meakin, B.³ Brambilla, G.⁴ Garzia, R.⁵

26
- 0010128315
- pMDI optimization using an actuator flow model
- (1998) Proceedings of RDD VI , pp. 319-321
- Dunbar, C.A.¹ Hickey, A.J.²

27
- 0032790248
- (1999) International Journal oy Pharmaceutics , vol.186 , pp. 13-30
- Vervaet, C.¹ Byron, P.R.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.